Prime Medicine, Inc. (PRME) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 516.19M |
| Enterprise Value | 569.59M |
| P/E Ratio | -3.08 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 150.33 |
| Price/Book Ratio | 15.09 |
| Enterprise/Revenue | 166.3 |
| Enterprise/EBITDA | -3.75 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -46.13 |
| Operating Margin | -48.25 |
AD
Management Effectiveness
| Return On Assets | -0.75 |
| Return On Equity | -1.88 |
Income Statement
| Revenue | 4.63M |
| Revenue/Share | 0.02 |
| Gross Profit | -2.69M |
| EBITDA | -195.76M |
| Net Income | -201.14M |
| Diluted EPS | -1.35 |
Balance Sheet
| Total Cash | 95.07M |
| Total Cash/Share | 0.54 |
| Total Debt | 112.48M |
| Total Debt/Equity | 2.83 |
| Current Ratio | 3.05 |
| Book Value Per Share | 0.22 |
Price History
| 52-Week Change | -4.51 |
| 52-Week High | 6.94 |
| 52-Week Low | 2.67 |
| Moving Average 50 Days | 3.28 |
| Moving Average 200 Days | 3.56 |
Statistics
| Average Volume | 3.38M |
| Shares Outstanding | 180.62M |
| % Held by Institutions | 60.66 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
